Out of Specification(OOS)
A test result that falls outside the established acceptance criteria or specifications.
Usage Examples
- The OOS investigation identified a calculation error.
- Phase II OOS investigation reviewed manufacturing records.
- OOS results required batch disposition decision.
What is OOS?
Out of Specification (OOS) results are test results that fall outside predetermined acceptance criteria. OOS results trigger investigation to determine if the result reflects actual product quality or laboratory error.
FDA guidance outlines a phased investigation approach: Phase I (laboratory investigation) examines analyst technique, equipment, calculations, and sample integrity. If Phase I doesn't identify lab error, Phase II (full-scale investigation) examines manufacturing process and additional sampling.
OOS investigations must be timely, thorough, and scientifically sound. Retesting and resampling have specific requirements to prevent "testing into compliance."
Regulatory Context
This term appears most often in cmc & manufacturing workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 211, FDA OOS GUIDANCE.
When This Matters
- The OOS investigation identified a calculation error.
- Phase II OOS investigation reviewed manufacturing records.
- OOS results required batch disposition decision.
Common Mistakes
- Failing to align CMC change narratives with current CFR/ICH expectations.
- Submitting incomplete control strategy documentation.
- Separating manufacturing and regulatory review cycles too late in execution.
Related Regulations
Frequently Asked Questions
OOS results can only be invalidated if a definitive, assignable laboratory cause is identified. Results cannot be invalidated simply because they are unexpected or inconvenient.
OOS (Out of Specification) results exceed acceptance criteria. OOT (Out of Trend) results meet specifications but show an unusual pattern or deviation from historical data, potentially indicating process drift.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Track ICH quality guidelines automatically and get alerts when changes impact your products
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References

